Regulatory Approval
Fermenta Biotech Receives FSSAI Approval for Plant-Based Vitamin D3 (VITADEE Green®)
NSE
FErmenta
BSE
506414
Fermenta Biotech Limited has received approval from the Food Safety and Standards Authority of India (FSSAI) for its plant-source Vitamin D3 (Cholecalciferol), VITADEE Green®, for use as an ingredient in health supplements, nutraceuticals, and food products. The approval expands the commercial opportunity for the company’s plant-based Vitamin D3 solution in the Indian market and supports domestic manufacturing under the Make in India initiative.
PRICE-SENSITIVE TRIGGER
Event: FSSAI Approval for Plant-Based Vitamin D3 (VITADEE Green®)
Type: Regulatory Approval
Impact: Positive
Immediate Effect: The approval enables Fermenta Biotech to commercially supply its plant-based Vitamin D3 as an approved ingredient for health supplements, nutraceuticals and food products in India, significantly expanding its addressable domestic market.
Key Metrics:
- Revenue: Not Disclosed
- EBITDA: Not Disclosed
- PAT: Not Disclosed
- Margins: Not Disclosed
- QoQ / YoY Movement: Not Applicable
- Segment Performance: Not Disclosed
Highlight:
- Commercial Opportunity: The regulatory approval allows commercialization of VITADEE Green® in India’s food, nutraceutical and health supplement industries. No financial guidance or revenue estimates have been disclosed.
What Happened ?
Fermenta Biotech Limited announced that its Vitamin D3 (Cholecalciferol) – Plant Source (VITADEE Green®) has received approval from the Food Safety and Standards Authority of India (FSSAI).
The approval permits its use as an ingredient in health supplements, nutraceuticals and food products, allowing Indian manufacturers to incorporate the company’s plant-based Vitamin D3 into a broad range of nutritional and fortified food applications.
Key Details
Order Details:
- FSSAI has approved VITADEE Green®, Fermenta’s plant-source Vitamin D3 (Cholecalciferol).
- The approval covers use in health supplements, nutraceuticals and food products.
- The product offers a plant-based Vitamin D3 alternative manufactured in India.
- The company stated that the product is supported by an Indian process patent.
- The approval opens opportunities in food fortification, dietary supplements and functional nutrition products.
- The product has been positioned to address India’s widespread Vitamin D deficiency through sustainable nutrition solutions.
- Fermenta stated that the approval supports the Make in India initiative by providing a domestically manufactured Vitamin D3 solution.
- The company expects the approval to strengthen its leadership in science-based Vitamin D3 solutions for the Indian market.
Note:
- The approval represents an important regulatory milestone that expands Fermenta’s product portfolio into the growing plant-based nutrition segment while supporting increasing demand for sustainable and locally manufactured nutritional ingredients.
Risk Analysis
Summary:
- The regulatory approval creates a new commercial opportunity; however, financial benefits will depend on customer adoption, product commercialization and competitive dynamics within the nutrition ingredients market.
Key Risks:
- The company has not disclosed expected revenue or profitability from the approval.
- Commercial success depends on adoption by food, nutraceutical and supplement manufacturers.
- Market competition from domestic and international Vitamin D ingredient suppliers may affect growth.
- Future sales will depend on execution of commercialization and customer acquisition strategies.
Worst Case:
- If customer adoption remains slower than anticipated or commercialization is delayed, the regulatory approval may not immediately translate into meaningful revenue growth.
Risk Level: Low
Company Commentary
- Fermenta’s VITADEE Green® has received FSSAI approval for use in health supplements, nutraceuticals and food products.
- The approval expands access to a sustainable, scalable and plant-based Vitamin D3 solution for the Indian market.
- The company stated that the product supports India’s Make in India initiative through domestic manufacturing.
- Management believes the approval will help address widespread Vitamin D deficiency by providing an indigenous, science-backed nutritional ingredient.
- The company highlighted that VITADEE Green® offers Indian formulators a plant-source Vitamin D3 alternative for food fortification and nutrition products.
Official Exchange Filing: Fermenta Biotech Limited
